760 / 1224
/
M Guckenberger - SBRT stage I NSCLC - HICARE 2015
18
Interstitial lung disease
ILD as exclusion criteria for SBRT
Study
Interstitial lung
disease
Overall patients / % patients with ILD
SBRT dose
Radiation
penumonitis
Takeda
Lung cancer 2015
124 –
16%
4 x 12Gy
G2-5 19%
Ueki
JTO 2015
157 –
13%
4 x 12Gy
G3+ 55%
Bahig
PRO 2016
504 –
6%
G3+ 32%
G5 21%
Yoshitake
Anticancer Res 2015
260 –
8%
G2+ 50%
G5 17%